OTORIO-AC – Gentamicin 0.3%w/v,Clotrimazole 1.0%w/v,Lignocaine Hcl 2.0%w/v,Beclomethasone Diproprionate 0.025%w/v Ear Drops
Generic Medicine Name: Gentamicin 0.3%w/v,Clotrimazole 1.0%w/v,Lignocaine Hcl 2.0%w/v,Beclomethasone Diproprionate 0.025%w/v Ear Drops (EYE AND EAR DROPS)
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | OTORIO-AC |
| Active Formulation (Salt) | Gentamicin 0.3%w/v,Clotrimazole 1.0%w/v,Lignocaine Hcl 2.0%w/v,Beclomethasone Diproprionate 0.025%w/v Ear Drops |
| Dosage Form | EYE AND EAR DROPS |
| Packaging Presentation | 5ml |
| Therapeutic Category | EYE AND EAR DROPS |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is OTORIO-AC (Gentamicin 0.3%w/v,Clotrimazole 1.0%w/v,Lignocaine Hcl 2.0%w/v,Beclomethasone Diproprionate 0.025%w/v Ear)?
Therapeutic monograph and clinical profile
OTORIO-AC (Gentamicin 0.3%w/v,Clotrimazole 1.0%w/v,Lignocaine Hcl 2.0%w/v,Beclomethasone Diproprionate 0.025%w/v Ear Drops) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 5ml, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Mixed Bacterial and Fungal Otitis Externa/ Severe Ear Inflammation.
Key Formulation Highlights
Why healthcare professionals recommend OTORIO-AC
Gentamicin 0.3%w/v,Clotrimazole 1.0%w/v,Lignocaine Hcl 2.0%w/v,Beclomethasone Diproprionate 0.025%w/v Ear Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Mixed Bacterial and Fungal Otitis Externa/ Severe Ear Inflammation
Pharmacological Mechanism of Gentamicin 0.3%w/v,Clotrimazole 1.0%w/v,Lignocaine Hcl 2.0%w/v,Beclomethasone Diproprionate 0.025%w/v Ear
How OTORIO-AC acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for OTORIO-AC
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for OTORIO-AC across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding OTORIO-AC
What is OTORIO-AC used for?
What is the active composition of OTORIO-AC?
How can I get monopoly PCD franchise for OTORIO-AC in my district?
What is the packaging and MRP of OTORIO-AC?
Related Formulations in EYE AND EAR DROPS
Explore complementary WHO-GMP certified healthcare formulations
